Aldeyra Therapeutics, Inc. - Common Stock - Mali Tablolar (NASDAQ:ALDX) | MetaTrader

Tam grafiği aç Full chart

Haberler

Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com

Aldeyra Therapeutics yönetim kurulu üyesi Martin J. Joyce görevden ayrılıyor

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

Aldeyra Therapeutics, 15 milyon dolarlık Hercules kredisini ödedi

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

H.C. Wainwright, FDA engeli sonrası Aldeyra hissesini düşürdü

FDA’dan ret sonrası BTIG, Aldeyra hissesi için Al tavsiyesini korudu

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC, rakip gecikmesi sonrası Bausch & Lomb notunu korudu

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?